These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7651732)
1. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Knippschild U; Kolzau T; Deppert W Oncogene; 1995 Aug; 11(4):683-90. PubMed ID: 7651732 [TBL] [Abstract][Full Text] [Related]
2. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Knippschild U; Oren M; Deppert W Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896 [TBL] [Abstract][Full Text] [Related]
3. The loss of mdm2 induces p53-mediated apoptosis. de Rozieres S; Maya R; Oren M; Lozano G Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826 [TBL] [Abstract][Full Text] [Related]
4. Selective compartmentalization of different mdm2 proteins within the nucleus. Maxwell SA Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679 [TBL] [Abstract][Full Text] [Related]
5. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270 [TBL] [Abstract][Full Text] [Related]
6. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022 [TBL] [Abstract][Full Text] [Related]
7. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649 [TBL] [Abstract][Full Text] [Related]
8. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991 [TBL] [Abstract][Full Text] [Related]
9. The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of Ras-transformed embryo fibroblasts growth arrest. Delphin C; Baudier J J Biol Chem; 1994 Nov; 269(47):29579-87. PubMed ID: 7961944 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. O'Connor PM; Jackman J; Bae I; Myers TG; Fan S; Mutoh M; Scudiero DA; Monks A; Sausville EA; Weinstein JN; Friend S; Fornace AJ; Kohn KW Cancer Res; 1997 Oct; 57(19):4285-300. PubMed ID: 9331090 [TBL] [Abstract][Full Text] [Related]
11. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Mdm2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cells. Hosokawa K; Aharoni D; Dantes A; Shaulian E; Schere-Levy C; Atzmon R; Kotsuji F; Oren M; Vlodavsky I; Amsterdam A Endocrinology; 1998 Nov; 139(11):4688-700. PubMed ID: 9794481 [TBL] [Abstract][Full Text] [Related]
13. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent. Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788 [TBL] [Abstract][Full Text] [Related]
14. Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. Gudas JM; Nguyen H; Li T; Sadzewicz L; Robey R; Wosikowski K; Cowan KH Carcinogenesis; 1996 Jul; 17(7):1417-27. PubMed ID: 8706243 [TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. Wesierska-Gadek J; Schmid G Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635 [TBL] [Abstract][Full Text] [Related]
16. A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down. Hirano Y; Yamato K; Tsuchida N Oncogene; 1995 May; 10(10):1879-85. PubMed ID: 7761089 [TBL] [Abstract][Full Text] [Related]
17. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation. Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121 [TBL] [Abstract][Full Text] [Related]
18. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells. Dilla T; Velasco JA; Medina DL; González-Palacios JF; Santisteban P Endocrinology; 2000 Jan; 141(1):420-9. PubMed ID: 10614665 [TBL] [Abstract][Full Text] [Related]
19. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells. Dong YB; Yang HL; Elliott MJ; McMasters KM Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line. Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]